Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Basal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04349436
What this trial is testing

Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies

Who this might be right for
Merkel Cell CarcinomaBasal Cell CarcinomaLocally Advanced Cutaneous Squamous Cell Carcinoma+1 more
Replimune, Inc. 69
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Testing effectiveness (Phase 2)Study completedNCT01367665
What this trial is testing

STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Hoffmann-La Roche 1,232
Early research (Phase 1)Study completedNCT00019110
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

Who this might be right for
Anal CancerCervical CancerEsophageal Cancer+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808515
What this trial is testing

A Study Comparing Cemiplimab-based Treatments for Adult Participants With Locally Advanced Basal Cell Skin Cancer (laBCC)

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Regeneron Pharmaceuticals 135
Post-approval studies (Phase 4)Study completedNCT06880848
What this trial is testing

Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China

Who this might be right for
Carcinoma, Basal Cell (BCC)
Jemincare 160
Not applicableStudy completedNCT04066504
What this trial is testing

Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Sun Pharmaceutical Industries Limited 323
Not applicableStudy completedNCT02781389
What this trial is testing

Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions

Who this might be right for
Basal Cell Carcinoma
University Hospital, Essen 53
Testing effectiveness (Phase 2)Looking for participantsNCT05561634
What this trial is testing

Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma

Who this might be right for
Basal Cell CarcinomaRadiotherapy; Complications
University Hospital, Lille 82
Testing effectiveness (Phase 2)Study completedNCT01835626
What this trial is testing

Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma

Who this might be right for
Locally Advanced Basal Cell CarcinomaSkin CancerCutaneous Malignancy
Sue Yom 24
Not applicableStudy completedNCT02100111
What this trial is testing

An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer Participants

Who this might be right for
Basal Cell Carcinoma
Hoffmann-La Roche 134
Early research (Phase 1)Study completedNCT03458117
What this trial is testing

T-VEC in Non-melanoma Skin Cancer

Who this might be right for
Non-melanoma Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma+2 more
University of Zurich 26
Testing effectiveness (Phase 2)Looking for participantsNCT03521830
What this trial is testing

Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 57
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Not applicableStudy completedNCT02674009
What this trial is testing

Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC)

Who this might be right for
Carcinoma, Basal Cell
Hoffmann-La Roche 67
Testing effectiveness (Phase 2)Study completedNCT01700049
What this trial is testing

Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes

Who this might be right for
Basal Cell Carcinoma
Mayo Clinic 28
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)